4.7 Article

Cholinergic forebrain degeneration in the APPswe/PSI1ΔE9 transgenic mouse

Journal

NEUROBIOLOGY OF DISEASE
Volume 28, Issue 1, Pages 3-15

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.nbd.2007.06.015

Keywords

Alzheimer's disease; amyloid; forebrain; transgenics; acetylcholine; ChAT activity; AChE; stereology; interneurons; degeneration

Categories

Funding

  1. NIA NIH HHS [R01 AG043375, R01 AG010668-14A1, R01 AG010668, P01 AG014449] Funding Source: Medline

Ask authors/readers for more resources

The impact of Delta beta deposition upon cholinergic intrinsic cortical and striatal, as well as basal forebrain long projection neuronal systems was qualitatively and quantitatively evaluated in young (2-6 months) and middle-aged (10-16 months) APPswe/PS1 Delta E9 transgenic (tg) mice. Cholinergic neuritic swellings occurred as early as 2-3 months of age in the cortex and hippocampus and 5-6 months in the striatum of tg mice. However, cholinergic neuron number or choline acetyltransferase (ChAT) optical density measurements remained unchanged in the forebrain structures with age in APPswe/PS1 Delta E9 tg mice. ChAT enzyme activity decreased significantly in the cortex and hippocampus of middle-aged tg mice. These results suggest that A 0 deposition has age-dependent effects on cortical and hippocampal ChAT fiber networks and enzyme activity, but does not impact the survival of cholinergic intrinsic or long projection forebrain neurons in APPswe/ PS1 Delta E9 tg mice. (C) 2007 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available